Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

homeHome
play_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn PresssearchSearch
settingsInstructions
bookmarkJournal InformationgroupsBoards and CommitteesshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
euroAPC
Authors GuideSubmit Manuscript

Outlines

https://doi.org/10.5812/ijem.5014

Mid-Trimester Maternal Serum hCG and Alpha Fetal Protein Levels: Clinical Significance and Prediction of Adverse Pregnancy Outcome

Author(s):
Georgios AndroutsopoulosGeorgios Androutsopoulos1,*, Panagiotis GkogkosPanagiotis Gkogkos1, Georgios DecavalasGeorgios Decavalas1
1Department of Obstetrics and Gynaecology, University of Patras, Medical School, Rion, Greece
International Journal of Endocrinology and Metabolism:Vol. 11, issue 2; 102-6
Published online:Mar 31, 2013
Article type:Review Article
Received:Apr 02, 2012
Accepted:Oct 07, 2012
How to Cite:Androutsopoulos G, Gkogkos P, Decavalas G. Mid-Trimester Maternal Serum hCG and Alpha Fetal Protein Levels: Clinical Significance and Prediction of Adverse Pregnancy Outcome. Int J Endocrinol Metab. 2013;11(2):. doi: https://doi.org/10.5812/ijem.5014

Abstract

Context:

Maternal serum human Chorionic Gonadotropin (hCG) and Alpha Fetal Protein (AFP) were originally introduced to detect trisomy 21 and neural tube defects. However, in the absence of aneuploidy or neural tube defects, mid-trimester maternal serum hCG and/or maternal serum AFP associated with adverse pregnancy outcomes. Pregnancies with unexplained mid-trimester elevation in maternal serum hCG and/or maternal serum AFP, are at increased risk for pregnancy complications resulting from placental insufficiency.

Evidence Acquisition:

Mid-trimester maternal serum hCG>2.5 MoM associated with an increased risk for pregnancy complications including: late fetal loss, gestational hypertension, preeclampsia, intrauterine growth restriction (IUGR), preterm delivery and intrauterine fetal death(IUFD). Mid-trimester maternal serum AFP levels >2.5 MoM are thought to reflect a defect in placentation and associated with an increased risk for pregnancy complications including: late fetal loss, gestational hypertension, preeclampsia, IUGR, preterm delivery and IUFD.

Results:

Combined mid-trimester elevation in maternal serum hCG and AFP levels suggest a more complex type of placental pathology. They have stronger association with pregnancy complications including: late fetal loss, gestational hypertension, preeclampsia, IUGR, preterm delivery and IUFD.

Conclusions:

Mid-trimester maternal serum hCG or AFP levels alone cannot detect all pregnant women with increased risk to develop pregnancy complications. Multiparameter testing of placental function in mid-trimester (maternal serum hCG and AFP screening, uterine artery Doppler and placental morphology) may allow us to identify women with increased risk to develop severe placental insufficiency and pregnancy complications. However, future prospective studies are needed to confirm the prognostic significance of multiparameter testing of placental function in mid-trimester.

Keywords
Maternal Serum Screening Tests
Chorionic Gonadotropin
AFP
Adverse Pregnancy Outcome

Full Text

Full text is available in PDF

Similar Articles

27
Oct
2021

Evaluation of Second-Trimester Maternal Serum AFP Value in the Detection of Congenital Heart Defects

Shahrzad Aghaamoo,
Maryam Lotfi,
Majid Mirmohammadkhani,
Mohammad Nasir Hemmatian
18
Apr
2022

Placental Size and Uterine Artery Doppler for Prediction of Adverse Pregnancy Outcomes in Women with Low Pregnancy-Associated Plasma Protein-A

Ashraf Jamal,
Shohreh Vosoogh,
Razieh Sadat Tabatabaei,
Fatemeh Salamat
6
May
2025

Serum Magnesium and Nitric Oxide Levels in Early Detection of Pre-eclampsia and Gestational Hypertension

Jenu Maria Thomas,
Revathi P Shenoy,
Parvati V Bhat,
Asha Kamath,
Krishnananda Prabhu,
Shashikiran Umakanth
30
Sep
2017

Predictive Power of Human Chorionic Gonadotropin in Post-Molar Gestational Trophoblastic Neoplasia: A Longitudinal Roc Analysis

Azin Khosravirad,
Farid Zayeri,
Ahmad Reza Baghestani,
Moein Yoosefi,
Mahmood Bakhtiyari
31
Mar
2023

The Relationship Between the Full Biophysical Profile and Rapid Biophysical Profile in Antepartum Fetal Surveillance

Hamideh Pakniat,
Ezzatalsadat Hajiseid Javadi,
Venus Chegini,
Nahid Khajevand,
Simindokht Molaverdikhani
Import into EndNoteImport into BibTex
Crossmark
Crossmark
Checking
Share on
Comments
Number of Comments:0
Cited by
Metrics
Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles

Related Article in PubMed

Related Article in Google Scholar

Create Citation Alert via Google Reader